AEMD Market Cap History
Below is a table of the AEMD market cap history going back to 4/14/2015:

Date AEMD Market Cap
4/14/201579.27M
6/25/201551.75M
7/13/201568.04M
8/13/201557.23M
11/13/201553.69M
2/4/201645.73M
6/29/201645.58M
8/11/201658.76M
11/8/201635.54M
2/10/201729.94M
6/28/201721.02M
8/10/201712.81M
11/2/201714.79M
1/31/201824.87M
6/8/201823.09M
8/8/201822.25M
11/6/201820.89M
2/11/201925.98M
6/27/20196.69M
8/14/20195.12M
10/15/20195.21M
10/31/20196.49M
2/7/202023.88M
6/23/202024.47M
8/10/202024.14M
10/27/202018.13M
2/4/202130.19M
6/21/202179.59M
8/4/202185.24M
11/5/202150.66M

Also see: AEMD Shares Outstanding History
and AEMD YTD Return
AEMD Historical Market Cap:
-6.59% CAGR
AEMD Historical Market Cap: +-6.59% CAGR

Mouse over chart for data details
4/14/2015 ...11/5/2021
Aethlon Medical is a medical technology company. The Aethlon Hemopurifier® is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The U.S. Food and Drug Administration has designated the Hemopurifier as a Breakthrough Device for two independent indications: the treatment of individuals with metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease; and the treatment of life-threatening viruses that are not addressed with approved therapies. We show 30 historical shares outstanding datapoints in our AEMD shares outstanding history coverage, used to compute AEMD market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AEMD market cap history over the course of time is important for investors interested in comparing AEMD's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AEMD versus a peer is one thing; comparing AEMD market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AEMD can fluctuate over the course of history. With this page we aim to empower investors researching AEMD by allowing them to research the AEMD market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AEMD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aethlon Medical (AEMD) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AERI Market Cap History
AEZS Market Cap History
AFIB Market Cap History
AGEN Market Cap History
AGIO Market Cap History
AGL Market Cap History
AGLE Market Cap History
AGN Market Cap History
AGRX Market Cap History
AGTC Market Cap History
More Healthcare companies »

 

AEMD Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.